June 2024 ZOHU Call/Webinar

What to know

A video recording of this webinar is posted below. Visit CDC TRAIN to get free continuing education (CE) for this webinar. The AAVSB/RACE credit is available.

1 hour

Jun 5, 2024

Webinar details

Presentation topics

• Updates to CDC Dog Regulation, Effective August 1, 2024

• Petting zoo perils: Findings from two outbreaks of Shiga toxin-producing Escherichia coli related to animal contact in 2023

Zoonoses and One Health Updates (ZOHU) Newsletter‎

Subscribe to the newsletter to receive monthly ZOHU news and updates.

Watch the webinar

Featuring

Mark Freedman, DVM, MPH, DACVPM | Presenter
Veterinary Medical Officer
Division of Global Migration and Quarantine, Centers for Disease Control and Prevention
Angelica Barrall, PhD, MPH | Presenter
EIS Officer Assigned to:
Outbreak Response and Prevention Branch, Centers for Disease Control and Prevention
Christine Thomas, DO, MPH | Presenter
EIS Officer Assigned to:
Tennessee Department of Health, Centers for Disease Control and Prevention

Continuing Education (CE)

Visit CDC Train to receive continuing education (CE) for this web-on-demand course. The AAVSB/RACE credit is now available for this course.

Web-on-Demand (Recording)

  • Course Name: WD4565(SC)-060524
  • Registration Code: ZOHUwebcast
  • Start Date: July 9, 2024
  • End Date: July 9, 2026

Series objectives

  1. Identify an implication for human, animal, and environmental health.
  2. Identify a One Health approach strategy for prevention of public health threats.
  3. Identify a One Health approach strategy for detection of public health threats.
  4. Identify a One Health approach strategy for responding to public health threats.
  5. List two ways to improve collaborative practice across the public healthcare team.

Disclosures

In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months.

CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.